Ovarian Endometrioid Tumor (DBCOND0073747)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02446600	Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Carboplatin Cediranib Doxorubicin Gemcitabine Olaparib Paclitaxel Tetracycline	treatment	3	active_not_recruiting
NCT05226507	A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer	No drug interventions	treatment	1	recruiting
NCT04510584	Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer	Atezolizumab Bevacizumab	treatment	2	withdrawn
NCT03685695	Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	No drug interventions	supportive_care	2	completed
NCT02627443	Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Berzosertib Carboplatin Gemcitabine	treatment	1	active_not_recruiting
NCT02520115	Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer	Dexamethasone Valproic acid	treatment	1	completed